LBA7 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the KEYNOTE-177 study Asia subgroup.

Autor:	Yoshino, T.1 (AUTHOR), André, T.2 (AUTHOR), Kim, T.W.3 (AUTHOR), Yong, W.P.4 (AUTHOR), Shiu, K-K.5 (AUTHOR), Vittrup Jensen, B.6 (AUTHOR), Jensen, L.H.7 (AUTHOR), Punt, C.J.A.8 (AUTHOR), Smith, D.9 (AUTHOR), Garcia-Carbonero, R.10 (AUTHOR), Alcaide-Garcia, J.11 (AUTHOR), Gibbs, P.12 (AUTHOR), de la Fouchardiere, C.13 (AUTHOR), Rivera, F.14 (AUTHOR), Elez Fernandez, M.E.15 (AUTHOR), Le, D.T.16 (AUTHOR), Zuo, Y.17 (AUTHOR), Fogelman, D.18 (AUTHOR), Adelberg, D.E.18 (AUTHOR), Diaz, L.19 (AUTHOR)
Zdroj:	Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1502-S1503. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu